Related references
Note: Only part of the references are listed.Nonadherence in Hypertension: How to Develop and Implement Chemical Adherence Testing
Dan Lane et al.
HYPERTENSION (2022)
Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial
Kazuomi Kario et al.
HYPERTENSION RESEARCH (2022)
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium
David E. Kandzari et al.
CIRCULATION (2022)
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years
Christian Ott et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial
Felix Mahfoud et al.
LANCET (2022)
Blood pressure and its variability: classic and novel measurement techniques
Aletta E. Schutte et al.
NATURE REVIEWS CARDIOLOGY (2022)
Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model
Andrew S. P. Sharp et al.
JOURNAL OF HYPERTENSION (2022)
Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
Deepak L. Bhatt et al.
LANCET (2022)
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trial
Florian Rader et al.
EUROINTERVENTION (2022)
Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2021)
Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic
Reinhold Kreutz et al.
JOURNAL OF HYPERTENSION (2021)
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction
Giuseppe Mancia et al.
HYPERTENSION (2021)
Range and Cardiovascular Outcomes in Patients With Hypertension
Nayyra Fatani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial
Michel Azizi et al.
LANCET (2021)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure. An individual participant-level data meta-analysis
Denis Pouchain
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2021)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
Frank L. J. Visseren et al.
EUROPEAN HEART JOURNAL (2021)
Hypertension Control in the United States 2009 to 2018 Factors Underlying Falling Control Rates During 2015 to 2018 Across Age- and Race-Ethnicity Groups
Brent M. Egan et al.
HYPERTENSION (2021)
Racial/Ethnic Disparities in Hypertension Prevalence, Awareness, Treatment, and Control in the United States, 2013 to 2018
Rahul Aggarwal et al.
HYPERTENSION (2021)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
Kazem Rahimi et al.
LANCET (2021)
Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
Bin Zhou et al.
LANCET (2021)
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
Weili Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC)
Juhani Knuuti et al.
EUROPEAN HEART JOURNAL (2020)
The REDUCE HTN: REINFORCE Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension
Michael A. Weber et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2020)
Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension The ERADICATE-AF Randomized Clinical Trial
Jonathan S. Steinberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation
Raymond R. Townsend et al.
EUROINTERVENTION (2020)
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial
Michael Bohm et al.
LANCET (2020)
Device-based therapies for arterial hypertension
Lucas Lauder et al.
NATURE REVIEWS CARDIOLOGY (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
Randomized trials of invasive cardiovascular interventions that include a placebo control: a systematic review and meta-analysis
Lucas Lauder et al.
EUROPEAN HEART JOURNAL (2020)
Renal Denervation in High-Risk Patients With Hypertension
Felix Mahfoud et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
Christopher J. L. Murray et al.
LANCET (2020)
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis Practitioner-Based Nationwide JAMP Study
Kazuomi Kario et al.
CIRCULATION (2020)
Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2020)
Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Stefan D. Anker et al.
EUROPEAN HEART JOURNAL (2020)
A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN)
Karl Fengler et al.
CIRCULATION (2019)
Adherence in Hypertension A Review of Prevalence, Risk Factors, Impact, and Management
Michel Burnier et al.
CIRCULATION RESEARCH (2019)
Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry
Felix Mahfoud et al.
EUROPEAN HEART JOURNAL (2019)
Validation of two watch-type wearable blood pressure monitors according to the ANSI/AAMI/ISO81060-2:2013 guidelines: Omron HEM-6410T-ZM and HEM-6410T-ZL
Mitsuo Kuwabara et al.
JOURNAL OF CLINICAL HYPERTENSION (2019)
Patient preference for therapies in hypertension: a cross-sectional survey of German patients
Roland E. Schmieder et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Medication persistence to antihypertensive drug treatment - a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients
Miriam Qvarnstrom et al.
BLOOD PRESSURE (2019)
Transvascular Pacing of Aorticorenal Ganglia Provides a Testable Procedural Endpoint for Renal Artery Denervation
Pierre C. Qian et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies Insights From a Randomized Trial
Karl Fengler et al.
HYPERTENSION (2019)
Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes
Wen-Yi Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation
Reetu R. Singh et al.
HYPERTENSION (2019)
Overview of the 2018 US Food and Drug Administration Circulatory System Devices Panel Meeting on Device-Based Therapies for hypertension
Nauman Khalid et al.
CARDIOVASCULAR REVASCULARIZATION MEDICINE (2019)
Adaptive designs in clinical trials: why use them, and how to run and report them
Philip Pallmann et al.
BMC MEDICINE (2018)
Regression of organ damage following renal denervation in resistant hypertension: a meta-analysis
Athanasios Kordalis et al.
JOURNAL OF HYPERTENSION (2018)
Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension - WAVE IV
Roland E. Schmieder et al.
JOURNAL OF HYPERTENSION (2018)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E. Kandzari et al.
LANCET (2018)
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial
Michel Azizi et al.
LANCET (2018)
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams et al.
EUROPEAN HEART JOURNAL (2018)
Renal Denervation Prevents Heart Failure Progression Via Inhibition of the Renin-Angiotensin System
Thomas E. Sharp et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide
Joel M. Neutel et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney
David J. Polhemus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R. Townsend et al.
LANCET (2017)
Renal safety of catheter-based renal denervation: systematic review and meta-analysis
Margreet F. Sanders et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality A Systematic Review and Network Meta-analysis
Joshua D. Bundy et al.
JAMA CARDIOLOGY (2017)
Evaluation of Adherence Should Become an Integral Part of Assessment of Patients With Apparently Treatment-Resistant Hypertension
Elena Berra et al.
HYPERTENSION (2016)
Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial
Ole N. Mathiassen et al.
JOURNAL OF HYPERTENSION (2016)
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad et al.
LANCET (2016)
Historical Incidence of Spontaneous Lesions in Kidneys from Na⟨ve Swine Utilized In Interventional Renal Denervation Studies
Serge D. Rouselle et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2016)
Renal Artery Vasodilation May Be An Indicator of Successful Sympathetic Nerve Damage During Renal Denervation Procedure
Weijie Chen et al.
SCIENTIFIC REPORTS (2016)
Randomized Sham-Controlled Trial of Renal Sympathetic Denervation in Mild Resistant Hypertension
Steffen Desch et al.
HYPERTENSION (2015)
Noninferiority Trials Is a New Treatment Almost as Effective as Another?
Amy H. Kaji et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial
Michel Azizi et al.
LANCET (2015)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control
Jackson T. Wright et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Predictors of blood pressure response in the SYMPLICITY HTN-3 trial
David E. Kandzari et al.
EUROPEAN HEART JOURNAL (2015)
Reinnervation of Renal Afferent and Efferent Nerves at 5.5 and 11 Months After Catheter-Based Radiofrequency Renal Denervation In Sheep
Lindsea C. Booth et al.
HYPERTENSION (2015)
Reduced Effect of Percutaneous Renal Denervation on Blood Pressure in Patients With Isolated Systolic Hypertension
Sebastian Ewen et al.
HYPERTENSION (2015)
Non-adherence to cardiovascular medications
Kumaran Kolandaivelu et al.
EUROPEAN HEART JOURNAL (2014)
Cardiac Sympathetic Afferent Denervation Attenuates Cardiac Remodeling and Improves Cardiovascular Dysfunction in Rats With Heart Failure
Han-Jun Wang et al.
HYPERTENSION (2014)
Anatomic Assessment of Sympathetic Peri-Arterial Renal Nerves in Man
Kenichi Sakakura et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
A Controlled Trial of Renal Denervation for Resistant Hypertension
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: pre- and post-procedural comparison with the Simplicity® catheter system and the EnligHTN™ multi-electrode renal denervation catheter
Christian Templin et al.
EUROPEAN HEART JOURNAL (2013)
Catheter-based renal sympathetic denervation exerts acute and chronic effects on renal hemodynamics in swine
Costas Tsioufis et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Differential Effectiveness of Placebo Treatments A Systematic Review of Migraine Prophylaxis
Karin Meissner et al.
JAMA INTERNAL MEDICINE (2013)
Renal Sympathetic Denervation for Treatment of Drug-Resistant Hypertension One-Year Results From the Symplicity HTN-2 Randomized, Controlled Trial
Murray D. Esler et al.
CIRCULATION (2012)
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
Stuart J. Pocock et al.
EUROPEAN HEART JOURNAL (2012)
Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies
Alison M. Ward et al.
JOURNAL OF HYPERTENSION (2012)
A Randomized Comparison of Pulmonary Vein Isolation With Versus Without Concomitant Renal Artery Denervation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension
Evgeny Pokushalov et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Lifetime Risks of Cardiovascular Disease
Jarett D. Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Stent Placement in Patients With Atherosclerotic Renal Artery Stenosis and Impaired Renal Function A Randomized Trial
Liesbeth Bax et al.
ANNALS OF INTERNAL MEDICINE (2009)
Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren A 12-Month Randomized, Double-Blind Comparator Trial With Hydrochlorothiazide
Roland E. Schmieder et al.
CIRCULATION (2009)
Revascularization versus Medical Therapy for Renal-Artery Stenosis
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidemiology and Natural History of Atherosclerotic Renovascular Disease
Constantina Chrysochou et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2009)
Trends in Vascular Complications After Diagnostic Cardiac Catheterization and Percutaneous Coronary Intervention Via the Femoral Artery, 1998 to 2007
Robert J. Applegate et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2008)
Co-occurrence of risk factors for cardiovascular disease by social class: 1958 British birth cohort
C. Power et al.
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH (2008)
Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments:: A systematic review
Isabelle Boutron et al.
PLOS MEDICINE (2006)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Share Paper
